Should I Buy XP? XP 2026 Analysis

Should You Buy XP Inc (XP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

19.390

1 Day change

4.02%

52 Week Range

20.980

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

XP is not a good buy right now for an impatient entry. The broader technical trend is still constructive (bullish moving averages), but near-term momentum is cooling and options flow is signaling short-term defensiveness (heavy put volume). With no Intellectia buy signals today and pattern-based odds skewing to slight downside over the next month, the better call is HOLD (or wait for either a breakout above ~20.67 or a dip closer to support ~19.20/17.72 before buying).

Technical Analysis

Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates an overall uptrend bias. Momentum: MACD histogram is positive (0.228) but “positively contracting,” suggesting bullish momentum is fading rather than accelerating. RSI(6)=54.76 is neutral—no oversold bounce signal. Levels: Pivot ~19.195 is the key near-term line. Resistance: R1 ~20.671 then R2 ~21.583. Support: S1 ~17.718 then S2 ~16.806. Price action context: Closed at 19.52 (-2.89% regular session), sitting only slightly above the pivot—technically ‘okay’ but not a strong momentum entry. Pattern-based projection: Similar-pattern study implies ~60% chance of -0.81% next day, +0.92% next week, and -3.47% next month—tilts against an immediate buy.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Positioning: Open-interest put/call ratio at 0.71 is moderately bullish (more call OI than put OI). Flow/sentiment: Put/call volume ratio at 4.51 is strongly bearish/defensive for the day (puts dominating trading activity), and volume is elevated vs 30-day average (~136%), implying heightened near-term hedging or bearish speculation. Volatility: IV (30d) ~42.56 vs HV ~34.48 suggests options are pricing in more movement than recent realized; IV percentile ~21.6 and IV rank ~10.43 indicate IV is relatively low vs its own history, but today’s put-heavy flow still leans cautious short-term.

Technical Summary

Sell

Buy

Positive Catalysts

reinforce a positive medium-term view.
showed solid YoY growth in revenue, net income, and EPS.
scheduled 2026-02-19 after hours could re-rate the stock if results/guide surprise positively.

Neutral/Negative Catalysts

alongside a -2.89% down day—signals near-term caution.

Financial Performance

Latest quarter: 2025/Q3. Growth: Revenue 4,660,687,000 (+7.92% YoY), Net Income 1,319,621,000 (+11.27% YoY), EPS 2.47 (+13.30% YoY). Overall, profitability and earnings are growing faster than revenue, a constructive signal. Note: Gross margin field is shown as 0 (likely data issue), so margin trend can’t be reliably assessed from the snapshot provided.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Analyst tone is positive and price targets moved up/initiated at premiums to current price.

2025-12-16: UBS raised PT to $25 (from $23), maintained Buy.
2026-01-19: Jefferies initiated Buy with $22 PT, highlighting strong competitive position and ~26% ROE. Wall Street pro view (from provided data): Pros—strong Brazil wealth/distribution position, attractive ROE, and improving targets. Cons—near-term trading sentiment is defensive (put-heavy) and hedge-fund selling suggests some smart-money de-risking. Politicians/influential figures: No congress trading data in the last 90 days; no politician activity provided.

3 Analyst Rating

Wall Street analysts forecast XP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XP is 24.33 USD with a low forecast of 22 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 18.640

Low

Averages

24.33

High

Current: 18.640

Low

Averages

24.33

High

Jefferies

NULL -> Buy

initiated

$22

AI Analysis

2026-01-19

Reason

Jefferies

Price Target

$22

AI Analysis

2026-01-19

initiated

NULL -> Buy

Reason

Jefferies initiated coverage of XP Inc. with a Buy rating and $22 price target. XP is a broker democratizing investments in Brazil, the analyst tells investors in a research note. The firm says the company has a "very strong" competitive position in Brazil's wealth management market. XP's return on equity is 26% and it has a "dominant" position in distribution channel, contends Jefferies.

UBS

Thiago Batista

Buy

maintain

$23 -> $25

2025-12-16

Reason

UBS

Thiago Batista

Price Target

$23 -> $25

2025-12-16

maintain

Buy

Reason

UBS analyst Thiago Batista raised the firm's price target on XP Inc. to $25 from $23 and keeps a Buy rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for XP

Unlock Now

XP Should I Buy

XP Should I Buy

Should You Buy XP Inc (XP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch